Who Exports Ibrutinib from India — 103 Suppliers Behind a $1.0M Market
India's ibrutinib export market is supplied by 103 active exporters who collectively shipped $1.0M across 560 shipments. NIVIRA EXPORTS leads with a 23.8% market share, followed by VAMA LIFECARE PRIVATE LIMITED and RBN MEDITECH PRIVATE LIMITED. The top 5 suppliers together control 54.3% of total export value, reflecting a moderately competitive market structure.
Top Ibrutinib Exporters from India — Ranked by Export Value
NIVIRA EXPORTS is the leading ibrutinib exporter from India, holding a 23.8% share of the $1.0M market across 560 shipments from 103 exporters. The top 5 suppliers — NIVIRA EXPORTS, VAMA LIFECARE PRIVATE LIMITED, RBN MEDITECH PRIVATE LIMITED, SHREE KRISHNA LIFECARE, MEDIGEN PHARMA — collectively control 54.3% of total export value, indicating a moderately concentrated market. Individual shares are: NIVIRA EXPORTS (23.8%), VAMA LIFECARE PRIVATE LIMITED (20.2%), RBN MEDITECH PRIVATE LIMITED (4.1%), SHREE KRISHNA LIFECARE (3.3%), MEDIGEN PHARMA (2.9%).
Top Ibrutinib Exporters from India
Ranked by export value · 103 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | NIVIRA EXPORTS IBRUTINIB 140MG CAP - NITIBPHARMACEUTICALS -IBRUTINIB 140MG CAP | $239.9K | 2 | 23.8% |
| 2 | VAMA LIFECARE PRIVATE LIMITED | $203.2K | 1 | 20.2% |
| 3 | RBN MEDITECH PRIVATE LIMITED | $41.7K | 1 | 4.1% |
| 4 | SHREE KRISHNA LIFECARE NITIB CAP.IBRUTINIB CAPSULES 140MG1*30 CAP. AS PER DOCUMENTPHARMACEUTICAL PRODUCT :- IBRUNAT 140NITIB TAB. IBRUTINIB CAPSULES 140MG AS PER INVOICE | $32.7K | 1 | 3.3% |
| 5 | MEDIGEN PHARMA | $29.7K | 2 | 2.9% |
| 6 | RMPL PHARMA LLP NITIB 140 MGNITIB 140MGNITIB 140 MG 30CAP IBRUTINIB | $29.2K | 3 | 2.9% |
| 7 | RAVI PHARMA NITIB CAP.IBRUTINIB CAPSULES 140MG1*30 CAP. AS PER DOCUMENTNITIB TAB. IBRUTINIB CAPSULES 140MG AS PER INVOICENITIB 140 MGIBRUTINIB CAP. 140 MG AS PER INVOICE | $25.3K | 1 | 2.5% |
| 8 | JPC GLOBAL IBRUTINIB 140MG CAP - NITIBPHARMACEUTICALS -IBRUTINIB 140MG CAP | $20.9K | 3 | 2.1% |
| 9 | KALINDI OVERSEAS IBRUTINIB 140MG CAP - NITIBPHARMACEUTICALS -IBRUTINIB 140MG CAP | $20.6K | 2 | 2.0% |
| 10 | ROYAL MEDICAL PRIVATE LIMITED NITIB 140 MGNITIB 140 MG 30CAP IBRUTINIBNITIBBT NO.AC | $17.6K | 1 | 1.7% |
| 11 | BULL PHARMACHEM | $16.1K | 4 | 1.6% |
| 12 | CORSANTRUM TECHNOLOGY | $13.4K | 1 | 1.3% |
| 13 | M T MADON EXPORTS IBRUTINIBIBRUTINIB4650GMS6NITIB CAP.IBRUTINIB CAPSULES 140MG1*30 CAP. AS PER DOCUMENT | $11.7K | 3 | 1.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Ibrutinib exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Nivira Exports | Not Listed | Yes (as of 2023) | No | Not verified | Nivira Exports sources products from manufacturers accredited with WHO-GMP certi |
| Vama Lifecare Private Limited | Not Listed | Yes (as of 2023) | No | Not verified | Vama Lifecare Private Limited operates a WHO-GMP certified manufacturing facilit |
| Medigen Pharma | Not Listed | Yes (as of 2023) | No | Not verified | Medigen Pharma holds a WHO-GMP certification for its manufacturing processes. |
| RMPL Pharma LLP | Not Listed | Yes (as of 2023) | No | Not verified | RMPL Pharma LLP is certified under WHO-GMP standards. |
| Ravi Pharma | Not Listed | Yes (as of 2023) | No | Not verified | Ravi Pharma's manufacturing facility complies with WHO-GMP guidelines. |
| JPC Global | Not Listed | Yes (as of 2023) | No | Not verified | JPC Global maintains WHO-GMP certification for its production processes. |
| Kalindi Overseas | Not Listed | Yes (as of 2023) | No | Not verified | Kalindi Overseas operates under WHO-GMP certified standards. |
| Royal Medical Private Limited | Not Listed | Yes (as of 2023) | No | Not verified | Royal Medical Private Limited's manufacturing facility is WHO-GMP certified. |
TransData Nexus reviewed the regulatory standing of 8 leading Ibrutinib exporters from India. 0 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Ibrutinib sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for Active Pharmaceutical Ingredients (APIs) production. The city hosts numerous manufacturing facilities specializing in APIs, including those for oncology drugs like Ibrutinib. Companies in Hyderabad benefit from a well-established infrastructure, skilled workforce, and proximity to research institutions, making it a strategic location for sourcing high-quality APIs.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. This region is home to leading companies such as Alembic Pharmaceuticals, which has a significant presence in Vadodara. Alembic Pharmaceuticals manufactures and markets a wide range of pharmaceutical products, including formulations for therapeutic areas like oncology. The region's robust manufacturing capabilities and regulatory compliance make it a key area for sourcing finished Ibrutinib products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceutical products. Mumbai, being a major port city, facilitates the export of pharmaceuticals to global markets. The region's well-developed logistics and regulatory framework support efficient export operations, making it an advantageous location for companies involved in the international distribution of Ibrutinib.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh is known for its tax incentives and has attracted numerous pharmaceutical manufacturers. The region offers benefits such as excise duty exemptions and income tax holidays, reducing production costs. Manufacturers in this zone produce a variety of pharmaceutical products, including oncology drugs like Ibrutinib, leveraging the cost advantages to offer competitive pricing.
5Sourcing Recommendations
- Diversify Supplier Base: To mitigate risks associated with supplier concentration, consider engaging with multiple suppliers across different regions, including Hyderabad for APIs and Ahmedabad-Vadodara for formulations.
- Evaluate Supplier Credentials: Prioritize suppliers with certifications such as WHO-GMP and USFDA approvals to ensure compliance with international quality standards.
- Leverage Export Hubs: Utilize the Mumbai-Thane-Raigad region's export infrastructure for efficient international distribution of Ibrutinib products.
- Assess Cost Benefits: Explore sourcing from the Baddi-Nalagarh region to take advantage of tax incentives and potentially lower production costs.
By strategically sourcing from these key pharmaceutical clusters, TransData Nexus can optimize its supply chain for Ibrutinib, ensuring quality, cost-effectiveness, and reliability.
Common Questions — Ibrutinib Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which ibrutinib supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, NIVIRA EXPORTS leads with 60 recorded shipments worth $239.9K. VAMA LIFECARE PRIVATE LIMITED (60 shipments) and RBN MEDITECH PRIVATE LIMITED (6 shipments) are also established high-volume exporters.
Q How many ibrutinib manufacturers are there in India?
India has 103 active ibrutinib exporters with a combined export market of $1.0M across 560 shipments to 60 countries. The top 5 suppliers hold 54.3% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for ibrutinib from India?
Average FOB unit price: $742.98 per unit, ranging from $0.01 to $5638.88. Average shipment value: $1.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 103 verified Indian exporters of Ibrutinib ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 560 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 60 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
560 Verified Shipments
103 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists